Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
acquired immunodeficiency syndrome
acquired immunodeficiency syndrome dementia complex
acquired immunodeficiency syndrome, older adults
activated protein C resistance
aducanumab
advance directives
advances in neurology
adverse drug reaction
aerobic exercise
age associated memory impairment
aggression
agitation
algorithm
aluminum
Alzheimer's disease
Alzheimer's disease, conjugal
Alzheimer's disease, diagnosis of
Alzheimer's disease, driving with
Alzheimer's disease, early onset
Alzheimer's disease, early symptoms
Alzheimer's disease, familial
Alzheimer's disease, familial, late onset
Alzheimer's disease, incidence
Alzheimer's disease, misdiagnosis
Alzheimer's disease, pathogenesis
Alzheimer's disease, patient awareness of
Alzheimer's disease, preclinical
Alzheimer's disease, rapidly progressive
Alzheimer's disease, rate of clinical decline
Alzheimer's disease, risk factors in
Alzheimer's disease, treating associated medical problems in
Alzheimer's disease, treatment of
amnesia
amyloid
amyloid beta protein
amyloid beta protein antibodies
amyloid deposition
amyloid imaging
amyloid plaques
amyloidosis
amyloid-related imaging abnormalities
amyotrophic lateral sclerosis
anatomy of
angiotensin II receptor blocker
anti-amyloid therapy
anticoagulant, treatment
anticonvulsants
antihypertensive
antiphospholipid antibodies
antithrombin III deficiency
anxiety
apolipoprotein E
apoliprotein E, plasma level
APP
APP gene
asymptomatic
atrial fibrillation
atypical
automobile accidents
autonomic dysfunction
behavioral disorder
benzodiazepine
biologic markers
blacks
blood pressure
blood transfusion
bone density
carcinoma
caregiver
CAT scan
CAT scan, abnormal
CAT scan, emission
CAT scan, emission, abnormal
CAT scan, venography
cerebral edema
cerebral edema, vasogenic
cerebral infarction
cerebral venous infarction
cerebral venous thrombosis
cerebral venous thrombosis, deep
cerebral venous thrombosis, etiology
cerebral venous thrombosis, recurrent
cerebrospinal fluid
cerebrospinal fluid, abnormal
cerebrospinal fluid, biochemical markers of CNS disease
cerebrovascular accident
cerebrovascular accident, acute management of
cerebrovascular accident, familial occurrence
cerebrovascular accident, infancy and childhood
cerebrovascular accident, prevention of
cerebrovascular accident, thrombolytic agents in treatment
cerebrovascular accident, women
cerebrovascular accident, work up for
cerebrovascular accident, young adult
cerebrovascular disease
cerebrovascular disease, risk factors in
children
chromosomal abnormality
chromosome 12
cigarette smoking
clinical trials
cognition
comorbidities
complications
confusion
contraindications
controversies in neurology
cost
coumarin
craniectomy, decompressive
D-dimer
degenerative diseases of CNS
dementia
dementia, cerebrovascular disease causing
dementia, clinical diagnosis
dementia, diagnostic evaluation of
dementia, differential diagnosis of
dementia, driving with
dementia, early detection
dementia, familial
dementia, incidence
dementia, prevalence of
dementia, prevention of
dementia, rapidly progressive
dementia, screening for
dementia, treatment of
depression
diabetes mellitus
diagnostic criteria
disease modifying agents
dizziness
donanemab
donepezil
driving
drug abuse
dural sinus thrombosis
educational status
efficacy
electromagnetic fields
endovascular therapy
epidemiology of neurology
ethics in neurology
evidence-based research
exercise
Factor V Leiden
familial
fibrinolytic agents
fibrinolytic agents, intra-venous local infusion
fibrinolytic agents, utilization
fracture, long bone
gadolinium
gantenerumab
gender
gene
genetic counselling
genetic linkage
genetic neurologic disorders
genetic screening
genetic testing
glaucoma
haloperidol
head injury
headache
hemiparesis
hemosiderosis of CNS, superficial
heralding manifestation
herpes simplex virus
hip fracture
hippocampal atrophy
hippocampus
Hispanics
homocysteine, serum
homosexual
hormone replacement
hormone therapy
human immunodeficiency virus type 1
hydrocephalus
hypercholesterolemia
hyperhomocysteinemia
hyperinsulinism
hypertension
hypoxia
iatrogenic neurologic disorders
incidence
intellectual deficit
intellectual deterioration
intracerebral hemorrhage
intracranial pressure, increased
inverse association
Jakob-Creutzfeldt disease
lecanemab
leisure activity
level of consciousness, decreased
lifestyle
limbic system
limbic-predominant age-related TDP-43 encephalopathy
lipid lowering agent
managed care
marital status
medical-legal aspects of neurology
memory
memory, defect of recent
memory, evaluation of
memory, impairment of
memory, impairment of, isolated
memory, impairment of, subjective
meningitis
menopause
mental activity
mental status, abnormal
mesial temporal lobe
microhemorrhage, intracerebral
middle cerebral artery territory infarction
middle cerebral artery, occlusion of
mild cognitive impairment
mild cognitive impairment converting to Alzheimer's disease
mimics
Mini Mental Status Examination
misdiagnosis
molecular genetics
mongolism
monoclonal antibodies
mortality
motor neuron disease
MRI
MRI, abnormal
MRI, CAT scan compared to
MRI, contrast enhanced
MRI, functional
MRI, venography
multiple sclerosis
myoclonus
negative
nerve growth factor
neurofibrillary degeneration
neuroleptic
neuroleptic, atypical
neurologic complications of, systemic disease
neurologic consultation
neurologic disease, diagnoses of
neurologic evaluation
neurologic examination, focal
neurologic signs
neurologic symptoms
neuropathology
neuropathy
neuroprotective agents
nicotine
nonsteroidal anti-inflammatory drug
normal
occupational neurologic disorders
old age, driving and
old age, neurology of
oral contraceptives
oral contraceptives, cerbrovascular disease and
oral contraceptives, neurologic complications with
osteoporosis
Parkinson disease
Parkinson disease, etiology of
patient information and support
pitfalls
Pittsburgh Compound B
placebo
polysomnogram
practice guidelines
preclinical
pregnancy, neurologic complications in
premarin
presenilin-1 gene
presenilin-2 gene
prethrombotic state
prevention of neurologic disorders
progesterone
prognosis
protein C deficiency
protein S deficiency
proteinopathy
psychological testing
psychotic behavior
remternetug
research
review article
rhinorrhea, CSF
risk factors
risk factors, modification
risk-benefit assessment
risperidone
rosacea
safety
screening
seizure
seizure, elderly
seizure, focal
seizure, risk factors for
selective serotonin reuptake inhibitors
senile plaques
shared decision making
sildenafil
skin, lesions in neurologic disorders
sleep
sleep pathology and physiology
smell
Smell Identification Test
sodium-glucoe cotransporter-2 inhibitors
straight sinus
stress, emotional
superior sagittal sinus thrombosis
tau protein
TDP-43 proteinopathy
temporal lobe, atrophy
tissue plasminogen activator, intravenous
TRAILBLAZER-ALZ trial
treatment of neurologic disorder
TREM2 variants
water, drinking
weight loss
white matter disease
whites
workup
Showing articles 1000 to 1050 of 7385 << Previous Next >>

Incidental MRI Anomalies Suggestive of Multiple Sclerosis: The Radiologically Isolated Syndrome
Neurol 72:800-805,780, Okuda,D.T.,et al, 2009

Neurologic Immune Reconstitution Inflammatory Syndrome in HIV/AIDS: Outcome and Epidemiology
Neurol 72:835-841, McCombe,J.A.,et al, 2009

Cerebral Microbleed Preceding Symptomatic Intracerebral Hemorrhage in a Stroke-Free Person
Neurol 72:763-765, Vernooij,M.W.,et al, 2009

Treatment of CNS Sarcoidosis with Infliximab and Mycophenolate Mofetil
Neurol 72:337-340, Morovan,M. &Segal,B.M., 2009

Immunologic, Clinical, and Radiologic Status 14 Months After Cessation of Natalizumab Therapy
Neurol 72:396-401,392, Stuve,O.,et al, 2009

Pediatric Optic Neuritis: Brain MRI Abnormalities and Risk of Multiple Sclerosis
Neurol 72:881-885, Bonhomme,G.R.,et al, 2009

Weather and Air Pollution as Triggers of Severe Headaches
Neurol 72:922-927, Mukamal,K.J.,et al, 2009

Hepatitis B Vaccine and the Risk of CNS Inflammatory Demyelination in Childhood
Neurol 72:873-880,870, Mikaeloff,Y.,et al, 2009

Community-Acquired Bacterial Meningitis in Elderly Patients: Experience Over 30 Years
Medicine 88:115-119, Cabellos,C.,et al, 2009

Multiple Sclerosis Therapeutics: Unexpected Outcomes Clouding Undisputed Successes
Neurol 72:1008-1015, Wiendl,H. &Hohlfeld,R., 2009

Stroke in Women: An Evolving Topic
Stroke 40:1027-1028, Kurth,T. &Bousser,M.-G., 2009

Triple and Quadruple Spontaneous Cervical Artery Dissection: Presenting Characteristics and Long-Term Outcome
JNNP 80:171-174,130, Arnold,M.,et al, 2009

Analysis of 1008 Consecutive Patients Aged 15 to 49 with First-Ever Ischemic Stroke: The Helsinki Young Stroke Registry
Stroke 40:1195-1203, Putaala,J.,et al, 2009

Identifying Patients at High Risk for Poor Outcomes After Intra-Arterial Therapy for Acute Ischemic Stroke
Stroke 40:1780-1785, Hallevi,H.,et al, 2009

Combined Effect of Health Behaviours and Risk of First Ever Stroke in 20 040 Men and Women over 11 Years Follow-Up in Norfolk Cohort of European Prospective Investigation of Cancer (EPIC Norfolk): Prospective Population Study
BMJ 338:639-642, Myint,P.K.,et al, 2009

Genomewide Association Studies of Stroke
NEJM 360:1718-1728, Ikram,M.A.,et al, 2009

Opportunistic Infections and Other Risks with Newer Multiple Sclerosis Therapies
Ann Neurol 65:367-377, Berger,J.R. &Houff,S., 2009

Silent Ischemic Infarcts Are Associated with Hemorrhage Burden in Cerebral Amyloid Angiography
Neurol 72:1230-1235, Kimberly,W.T.,et al, 2009

Community-Acquired Bacterial Meningitis in Elderly Patients: Experience over 30 Years
Medicine 88:115-119, Cabellos,C.,et al, 2009

Diagnosis and New Treatment in Muscle Channelopathies
JNNP 80:360-365, Meola,G.,et al, 2009

Recurrent Pericarditis Due to Natalizumab Treatment
Neurol 72:1616-1617, Cohen,M.,et al, 2009

Progressive Multifocal Leukoencephalopathy and Relapsing-Remitting Multiple Sclerosis: A Comparative Study
Arch Neurol 66:593-599, Boster,A.,et al, 2009

Nonfasting Triglycerides and Risk of Ischemic Stroke in the General Population
JAMA 300:2142-1252, Freiberg,J.J.,et al, 2008

Intracranial Hemorrhage in Children
Arch Neurol 65:1629-1633, Lo,W.D.,et al, 2008

Natalizumab Use in Pediatric Multiple Sclerosis
Arch Neurol 65:1655-1658, Huppke,P.,et al, 2008

Recurrent Stroke and Massive Right-to-Left Shunt: Results from the Prospective Spanish Multicenter (CODICIA) Study
Stroke 39:3131-3136, Serena,J.,et al, 2008

Increased Stroke Risk Is Related to a Binge Drinking Habit
Stroke 39:3179-3184, Sundell,L.,et al, 2008

Atrial Fibrillation Detected by Mobile Cardiac Outpatient Telemetry in Cryptogenic TIA or Stroke
Neurol 71:1696-1701, Tayal,A.H.,et al, 2008

Decoding Cryptogenic Cardioembolism
Ann Neurol 64:364-365, Meschia,J.F., 2008

Managing the Anticoagulated Patient with Atrial Fibrillation at High Risk of Stroke Who Needs Coronary Intervention
BMJ 337:1110-1111, Lip,G.Y.H., 2008

Cerebral Venous Thrombosis: A Descriptive Multicenter Study of Patients in Pakistan and Middle East
Stroke 39:2707-2711, Khealani,B.,et al, 2008

Multiple Sclerosis
Lancet 372:1502-1517, Compston,A. &Coles,A., 2008

Alemtuzumab vs. Interferon Beta-1a in Early Multiple Sclerosis
NEJM 359:1786-1801,1838, The CAMMS223 Trial Investigators, 2008

Symptomatic Intracerebral Hemorrhage and Recanalization After IV rt-PA: A Multicenter Study
Neurol 71:1304-1312, Saqqur,M.,et al, 2008

Sudden Sensorineural Hearing Loss Increases the Risk of Stroke: A 5-Year Follow-Up Study
Stroke 39:2744-2748, Lin,H.-C.,et al, 2008

Effect of Fish Oil on Cognitive Performance in Older Subjects: A Randomized, Controlled Trial
Neurol 71:430-438, van de Rest,O.,et al., 2008

Fish Consumption and Risk of Subclinical Brain Abnormalities on MRI in Older Adults
Neurol 71:439-446, Virtanen,J.K.,et al., 2008

Restarting Anticoagulation Therapy After Warfarin-Associated Intracerebral Hemorrhage
Arch Neuol 65:1313-1318, Claassen,D.O.,et al, 2008

Predictors of Antecedent Factors in Psychogenic Nonepileptic Attacks: Multivariate Analysis
Neurol 71:1000-1005, Duncan,R. &Oto,M., 2008

Familiality in Brain Tumors
Neurol 71:1015-1020, Blumenthal,D.T.&Cannon-Albright,L.A., 2008

Exposure to Antipsychotics and Risk of Stroke: Self Controlled Case Series Study
BMJ 337:616-618,586, Douglas,I.J. &Smeeth,L., 2008

Phase 2 Safety Trial Targeting Amyloid � Production With a ?-Secretase Inhibitor in Alzheimer Disease
Arch Neurol 65:1031-1038, Fleisher,A.S.,et al., 2008

Ambient Air Pollution and Risk of Ischemic Stroke and Transient Ischemic Attack
Ann Neurol 64:53-59, Lisabeth,L.D.,et al., 2008

Large Artery Intracranial Occlusive Disease: A Large Worldwide Burden But a Relatively Neglected Frontier
Stroke 39:2396-2399, Gorelick,P.B.,et al., 2008

Anti-Tumor Necrosis Factor Alpha-Associated Multiple Sclerosis
AJNR 26:1548-1550, Titelbaum,D.S.,et al., 2008

Assessment: The Use of Natalizumab (Tysabri) for the Treatment of Multiple Sclerosis (An Evidence-Based Review): Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
Neurol 71:766-773, Goodin,D.S.,et al., 2008

Management of Stroke in Infants and Children: A Scientific Statement From a Special Writing Group of the American Heart Association Stroke Council and the Council on Cardiovascular Disease in the Young
Stroke 39:2644-2691, Roach,E.S.,et al., 2008

Stroke Location and Association With Fatal Cardiac Outcomes: Northern Manhattan Study (NOMAS)
Stroke 39:2425-2431, Rincon,F.,et al., 2008

SLC01B1 Variants and Statin-Induced Myopathy -- A Genomewide Study
NEJM 359:789-799, The SEARCH Collaborative Group, 2008

Drowning in People With Epilepsy: How Great is the Risk?
Neurol 71:578-582, Bell,G.S.,et al., 2008



Showing articles 1000 to 1050 of 7385 << Previous Next >>